Compare Abeona Therapeutics Inc (ABEO) vs DigitalOcean Holdings Inc (DOCN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs DigitalOcean Holdings Inc — how do they compare? Abeona Therapeutics Inc trades at $6.46 (market cap $362.83M), while DigitalOcean Holdings Inc trades at $132.55 (market cap $15.55B). The key difference: DigitalOcean Holdings Inc is far larger — about 42.9× Abeona Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| ABEO | DOCN | |
|---|---|---|
Market Cap | $362.83M | $15.55B |
Sector | Health | Technology |
52-Week High | $7.46 | $181.29 |
52-Week Low | $4.17 | $29.99 |
Enterprise Value | $235.88M | $16.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $7.46, up 0.81% today, with a bullish technical outlook supported by moving averages but overbought RSI signals. The company reported Q2 2026 revenue of $11.4 million, missing EPS estimates, yet maintains strong profitability margins and low valuations. Recent news highlights operational challenges with ZEVASKYN rollout but positive developments like CMS NTAP status.
Outlook is mixed: analyst consensus is bullish with 67% buy ratings, but risks include execution setbacks and shareholder investigations. Investment opportunity lies in growth potential if operational issues resolve, though high volatility and negative cash flows from operations pose near-term headwinds.
DigitalOcean (DOCN) trades at $132.29, up 9.46% today, showing strong momentum after recent earnings beats. The stock maintains a bullish technical signal with key support at $131 and resistance at $136. Fundamentally, the company demonstrates robust revenue growth (29% YoY in Q2 2026) and expanding profit margins, though valuation metrics remain elevated with a P/E of 60.62. Recent news highlights accelerating AI-native cloud demand and upward guidance revisions.
DOCN presents a growth opportunity with strong AI infrastructure positioning and consistent earnings outperformance, but faces risks from high valuation multiples and negative shareholder equity. Wall Street remains bullish with a $173.71 consensus target (31% upside), though investors should monitor debt levels and competitive pressures in the cloud services sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About DigitalOcean Holdings Inc
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and other countries.
Read more on DOCN →
